Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Oceanaa Biotek
Join Channel
Consolidated Standalone

Oceanaa Biotek

₹2.4 -0.2 | 8.4%

Market Cap ₹3 Cr.

Stock P/E -2.2

P/B 0.1

Current Price ₹2.4

Book Value ₹ 20.1

Face Value 10

52W High ₹0

Dividend Yield 0%

52W Low ₹ 0

Edit Ratio

Oceanaa Biotek Research see more...

Overview Inc. Year: 2005Industry: Aquaculture

Oceanaa Biotek Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Oceanaa Biotek Quarterly Results

#(Fig in Cr.) Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
Net Sales 14 8 3 5 5 3 13 5 4 1
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 14 8 3 5 5 3 13 5 4 1
Total Expenditure 11 7 27 3 3 2 13 3 3 2
Operating Profit 3 1 -24 2 2 1 -0 2 1 -1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 0 1 1 1 1 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 0 -24 1 1 1 -1 1 0 -1
Provision for Tax 1 0 0 -0 0 -0 0 0 0 -0
Profit After Tax 2 0 -24 1 1 1 -1 1 0 -1
Adjustments -0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 2 0 -24 1 1 1 -1 1 0 -1
Adjusted Earnings Per Share 1.2 0.1 -17.5 0.9 1 0.8 -1 0.9 0.1 -1.1

Oceanaa Biotek Profit & Loss

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
Net Sales 0 0 0 7 46 32 36 60 36 26 23
Other Income 0 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 7 46 32 36 61 36 26 23
Total Expenditure 0 0 0 6 44 27 31 39 54 21 21
Operating Profit -0 -0 0 1 2 5 5 21 -18 5 2
Interest 0 0 0 0 0 0 0 1 0 0 0
Depreciation 0 0 0 0 1 1 1 3 3 2 1
Exceptional Income / Expenses 0 0 0 -0 -0 -0 0 0 0 0 0
Profit Before Tax -0 -0 0 1 1 4 4 17 -21 2 -1
Provision for Tax 0 0 0 0 0 1 2 6 -1 0 0
Profit After Tax -0 -0 0 0 1 2 3 11 -20 2 -1
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 -0 0 0 1 2 3 11 -20 2 -1
Adjusted Earnings Per Share -12.4 -8.4 0.1 0.4 0.8 2.1 2.7 8.1 -14.8 1.6 -1.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -28% -10% -11% 0%
Operating Profit CAGR 0% 0% 20% 0%
PAT CAGR 0% -13% 15% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 0% -30% -34% -9%
ROE Average 8% -4% 6% 5%
ROCE Average 10% 4% 15% 11%

Oceanaa Biotek Balance Sheet

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Shareholder's Funds -0 -0 3 6 10 12 15 45 25 27
Minority's Interest 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 1 1 1
Other Non-Current Liabilities 0 0 0 -0 0 -0 0 1 0 0
Total Current Liabilities 0 0 0 4 3 7 7 13 13 12
Total Liabilities 0 0 3 10 13 19 22 60 39 41
Fixed Assets 0 0 0 0 7 7 6 24 17 21
Other Non-Current Assets 0 0 0 0 0 0 0 0 0 0
Total Current Assets 0 0 3 10 6 13 17 36 23 20
Total Assets 0 0 3 10 13 19 22 60 39 41

Oceanaa Biotek Cash Flow

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Opening Cash & Cash Equivalents 0 0 0 0 2 0 0 0 0 0
Cash Flow from Operating Activities 0 0 0 -0 2 1 1 2 -5 7
Cash Flow from Investing Activities 0 0 0 0 -8 -1 -0 -22 5 -6
Cash Flow from Financing Activities 0 0 0 2 4 -0 -0 20 -0 -0
Net Cash Inflow / Outflow 0 0 0 2 -2 0 -0 0 -0 0
Closing Cash & Cash Equivalent 0 0 0 2 0 0 0 0 0 0

Oceanaa Biotek Ratios

# Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Earnings Per Share (Rs) -12.45 -8.44 0.05 0.39 0.79 2.13 2.7 8.06 -14.78 1.63
CEPS(Rs) -12.45 -8.44 0.05 0.4 1.4 3.45 3.78 10.62 -12.94 3.23
DPS(Rs) 0 0 0 0 0 0.6 0.6 1.5 0 0
Book NAV/Share(Rs) -49.51 -45.11 5.77 6.21 10.02 11.73 14.8 33.35 18.62 20.26
Core EBITDA Margin(%) 0 -111.59 12.19 11.16 4.54 15.98 14.7 34.77 -49.33 18.45
EBIT Margin(%) 0 -111.59 12.19 8.68 2.85 11.35 11.8 29.16 -56.22 10.11
Pre Tax Margin(%) 0 -116.66 12.18 8.59 2.73 11 11.71 27.97 -56.68 9.71
PAT Margin (%) 0 -143.53 8.36 5.19 1.74 6.78 7.49 18.09 -55.27 8.64
Cash Profit Margin (%) 0 -143.53 8.36 5.3 3.08 10.95 10.5 23.82 -48.37 17.07
ROA(%) -63.4 -96.04 1.71 5.35 6.98 13.28 13.19 26.44 -40.26 5.53
ROE(%) 0 0 1.91 8.12 10.25 19.62 20.32 36.25 -56.88 8.41
ROCE(%) 0 0 2.76 13.58 16.7 32.59 31.89 57.2 -56.03 9.52
Receivable days 0 0 6.16 114.98 36.54 43.33 36.82 47.33 107.81 112.91
Inventory Days 0 0 184.11 0 0 53.68 47.93 34.2 35.01 9.19
Payable days 0 0 67.93 132.29 28.02 74.62 81.13 48.75 41.72 127.72
PER(x) 0 0 0 0 7.51 5.38 18.55 18.85 0 3.86
Price/Book(x) 0 0 0 0 0.59 0.98 3.38 4.56 1.3 0.31
Dividend Yield(%) 0 0 0 0 0 3.07 1.2 0.99 0 0
EV/Net Sales(x) 0 0.45 8.83 0.46 0.13 0.35 1.39 3.42 0.93 0.36
EV/Core EBITDA(x) -0.42 -0.4 72.45 4.12 2.9 2.22 9.32 9.81 -1.89 1.92
Net Sales Growth(%) 0 0 3300 1872.31 592.64 -30.82 13.43 65.83 -39.98 -29.29
EBIT Growth(%) -4131.82 47.26 471.54 1304.33 127.26 175.64 18.78 306.96 -215.7 112.73
PAT Growth(%) 0 32.18 298 1124.48 131.8 169.92 26.3 297.73 -283.36 111.06
EPS Growth(%) 0 32.18 100.64 631.24 101.59 169.92 26.3 199.06 -283.36 111.06
Debt/Equity(x) 0 0 0 0 0.01 0.01 0 0.03 0.04 0.03
Current Ratio(x) 0.01 0.11 12.86 2.31 1.88 1.68 2.33 2.75 1.75 1.6
Quick Ratio(x) 0.01 0.11 12.19 2.31 1.88 1.05 1.64 2.26 1.71 1.54
Interest Cover(x) -3778.41 -22.04 743.02 96.19 23.44 32.07 121.65 24.52 -121.91 25.05
Total Debt/Mcap(x) 0 0 0 0 0.02 0.01 0 0.01 0.03 0.09

Oceanaa Biotek Shareholding Pattern

# Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
Promoter 39.07 39.07 39.07 39.07 39.07 39.09 39.09 39.09 39.09 39.09
FII 0.02 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0.03 0 0 0 0
Public 60.91 60.93 60.93 60.93 60.93 60.88 60.91 60.91 60.91 60.91
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.1 times its book value
  • Company is almost debt free.

Cons

  • Promoter holding is low: 39.09%.
  • Company has a low return on equity of -4% over the last 3 years.
  • Debtor days have increased from 41.72 to 127.72days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Oceanaa Biotek News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!